Yoshimi Tanaka
- Nephrology top 10%
- Dialysis and Renal Disease Management 5
- Parathyroid Disorders and Treatments 3
-
- Renal cell carcinoma treatment 5
- Lung Cancer Treatments and Mutations 3
-
- HER2/EGFR in Cancer Research 4
-
- Renal and related cancers 4
-
- Pharmacological Effects and Toxicity Studies 3
-
- Nuclear and radioactivity studies 2
- Co-authors
- Chikara ΟhyamaShingo HatakeyamaTakuya KoieYasuhiro HashimotoTeppei OkamotoTohru YoneyamaToshikazu TanakaTakuma Narita
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yoshimi Tanaka
44 papers receiving 448 citations
Peers
Comparison fields: 5 of 118
- Nephrology 48
- Pulmonary and Respiratory Medicine 145
- Oncology 117
- Transplantation 8
- Radiology, Nuclear Medicine and Imaging 59
Countries citing papers authored by Yoshimi Tanaka
This map shows the geographic impact of Yoshimi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Tanaka more than expected).
Fields of papers citing papers by Yoshimi Tanaka
This network shows the impact of papers produced by Yoshimi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Tanaka. The network helps show where Yoshimi Tanaka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshimi Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2021 | 3 | |
| 6 | 2020 | 5 | |
| 7 | 2018 | 6 | |
| 8 | 2018 | 10 | |
| 9 | 2018 | 16 | |
| 10 | 2017 | 21 | |
| 11 | 2017 | 15 | |
| 12 | 2014 | 0 | |
| 13 | 2013 | 7 | |
| 14 | 2013 | 44 | |
| 15 | Neurophysiological study of remote rebound-effect of resistive static contraction of lower trunk on the flexor carpi radi alis H-reflex. | 2012 | 3 |
| 16 | Kidney as an important metabolic organ for recombinant human insulin-like growth factor-I. | 1997 | 4 |
| 17 | 1992 | 8 | |
| 18 | 1991 | 9 | |
| 19 | A PILOT TEST PLAN OF ROAD AUTOMOBILE COMMUNICATION SYSTEM | 1989 | 1 |
| 20 | 1985 | 16 |
About Yoshimi Tanaka
Yoshimi Tanaka is a scholar working on Nephrology, Family Practice and Pulmonary and Respiratory Medicine, having authored 49 papers that have together received 463 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Dialysis and Renal Disease Management (5 papers), HER2/EGFR in Cancer Research (4 papers), Renal and related cancers (4 papers), Parathyroid Disorders and Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Nuclear and radioactivity studies (2 papers). The work is most often cited by research in Nephrology (48 citations), Pulmonary and Respiratory Medicine (145 citations) and Oncology (117 citations). Yoshimi Tanaka has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Chikara Οhyama, Shingo Hatakeyama, Takuya Koie, Yasuhiro Hashimoto, Teppei Okamoto, Tohru Yoneyama, Toshikazu Tanaka, Shingo Hatakeyama, Takuma Narita and Itsuto Hamano. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.